Mabthera and respiratory failure 
Mabthera and respiratory failure Patient Reports March 22, 2010
Mabthera Side Effects Report #5649809-7
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Female patient, 68 years of age, was diagnosed with vasculitis
, cryoglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: confusional state, haemorrhage intracranial, pericardial effusion, pleural effusion, pyrexia, respiratory distress, respiratory failure, septic shock, thrombocytopenia. Mabthera dosage: 500 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, HYDROCORTISONE, LORATADINE, ACAMOL, PREDNISONE, CARBAMAZEPINE, ALFACALCIDOL, CALCIMORE. Patient was hospitalized. Patient died on 02/17/2008.Mabthera Side Effects Report #5863754-3
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Aug 17, 2008. Female patient, 17 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, herpes virus infection, oliguria, respiratory failure, sepsis
. Mabthera dosage: 1000 MG, UNK. Patient died on 06/22/2008.Mabthera Side Effects Report #5695032-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 25, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis
, hypothyroidism, hypersensitivity, premature menopause and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow toxicity, progressive multifocal leukoencephalopathy, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.Mabthera Side Effects Report #5705161-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: progressive multifocal leukoencephalopathy, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, CORTICOSTEROIDS, AMLODIPINE, CALCICHEW D. Patient died on 07/10/2006.Mabthera Side Effects Report #5817804-0
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 07, 2008. Female patient was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardiac failure, respiratory failure. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, CLEMASTIN. Patient died.
Mabthera Side Effects Report #5851763-X
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Aug 05, 2008. Female patient was diagnosed with systemic lupus erythematosus, hypothyroidism and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia aspiration, respiratory failure. Mabthera dosage: 375 MG/M2, 4/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, THYROXINE, CLARITIN, NUVELLE, FOLIC ACID, LEVOPROME. Patient died.
Mabthera Side Effects Report #5939367-1
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2008. Female patient was diagnosed with systemic lupus erythematosus, hypothyroidism and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia aspiration, respiratory failure. Mabthera dosage: 375 MG/M2, 4/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE, FOLIC ACID, LEVOMEPROMAZINE. Patient died.
Mabthera Side Effects Report #5951641-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 29, 2008. Male patient was diagnosed with scleroderma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pulmonary oedema, respiratory failure. Mabthera dosage: 375 MG/M2, UNK. Patient was hospitalized. Patient died.Mabthera Side Effects Report #5148328-4
Mabthera side effect was reported by a Physician from GERMANY on Oct 25, 2006. Female patient, 65 years of age, weighting 131.4 lb, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease recurrence, pulmonary fibrosis , respiratory failure. Mabthera dosage: 1000 MG, Q2W, INTRAVENOUS. During the same period patient was treated with AZATHIOPRIN, RISEDRONATE. Patient died on 07/29/2006.Mabthera Side Effects Report #5156699-8
Mabthera side effect was reported by a Physician from GERMANY on Oct 27, 2006. Female patient, 65 years of age, weighting 131.4 lb, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease recurrence, pulmonary fibrosis , respiratory failure. Mabthera dosage: 1000 MG, Q2W, INTRAVENOUS. During the same period patient was treated with AZATHIOPRIN, RISEDRONATE. Patient died on 07/29/2006.Mabthera Side Effects Report #5909497-9
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Mabthera dosage: unknown. Patient recovered.Mabthera Side Effects Report #5157956-1
Mabthera side effect was reported by a Physician from GERMANY on Oct 27, 2006. Female patient, weighting 131.4 lb, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, pulmonary fibrosis , respiratory failure. Mabthera dosage: 1000 MG, Q2W, UNK. During the same period patient was treated with AZATHIOPRIN, RISEDRONATE. Patient died.Mabthera Side Effects Report #6016024-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Dec 10, 2008. Female patient was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4977453-3
Mabthera side effect was reported by a Health Professional from GERMANY on Mar 31, 2006. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, febrile neutropenia, pancytopenia, pneumonia
, respiratory failure, thrombocytopenia. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 09/30/2004.Mabthera Side Effects Report #5023273-3
Mabthera side effect was reported by a Consumer or non-health professional from SPAIN on Sept 23, 2005. Male patient, 73 years of age, weighting 170.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac arrest , heart rate increased, obliterative bronchiolitis, respiratory failure. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, NICOTINE, DIGOXIN, GENTAMICIN, VENTOLIN. Patient died on 09/21/2005.Mabthera Side Effects Report #4992197-X
Mabthera side effect was reported by a Physician from NETHERLANDS on Apr 18, 2006. Male patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: herpes zoster, neutropenia, pneumocystis jiroveci pneumonia, respiratory failure, staphylococcal bacteraemia, weight decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEUPOGEN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4825052-6
Mabthera side effect was reported by a Physician from GERMANY on Oct 26, 2005. Female patient, 40 years of age, weighting 119.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, bronchoalveolar lavage abnormal, candidiasis, hypoxia, leukopenia, pneumocystis jiroveci pneumonia, respiratory failure. Mabthera dosage: 375 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5324275-X
Mabthera side effect was reported by a Physician from UNITED KINGDOM on May 04, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumocystis jiroveci pneumonia, respiratory failure, staphylococcal infection
. Mabthera dosage: 730 MG, Q2W. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE, FILGRASTIM, METHOTREXATE, ARABINOSIDO DE CITOSINA. Patient was hospitalized. Patient died on 04/03/2007.Mabthera Side Effects Report #5396757-6
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, weighting 149.9 lb, was diagnosed with non-hodgkin's lymphoma, lymphocytosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: abdominal pain
, dyspnoea, myalgia, respiratory failure. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient died on 03/24/2007.Mabthera Side Effects Report #5587535-3
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Jan 02, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, cytomegalovirus infection
, pneumocystis jiroveci pneumonia, respiratory failure. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with OCTAGAM. Patient died on 10/06/2007.Mabthera Side Effects Report #5268668-8
Mabthera side effect was reported by a Physician from NETHERLANDS on Mar 08, 2007. Female patient was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: infusion site extravasation, infusion site necrosis, respiratory failure, skin graft, transplant failure. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5162049-3
Mabthera side effect was reported by a Physician from NETHERLANDS on Nov 09, 2006. Female patient was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: extravasation, necrosis, respiratory failure. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #6134232-1
Mabthera side effect was reported by a Consumer or non-health professional from ITALY on Mar 18, 2009. Male patient was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hemianopia, progressive multifocal leukoencephalopathy, respiratory failure, visual field defect. Mabthera dosage: 770 MG, UNK. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
Mabthera Side Effects Report #5381075-2
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 27, 2007. Male patient, 71 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pulmonary fibrosis , respiratory failure. Mabthera dosage: 600 MG, 1/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient died on 06/01/2007.Mabthera Side Effects Report #5120077-8
Mabthera side effect was reported by a Health Professional from SPAIN on Sept 15, 2006. Female patient, 69 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, biopsy bone marrow abnormal, blast cells present, blood lactate dehydrogenase increased, leukocytosis, monocyte percentage increased, respiratory failure, thrombocytopenia. Mabthera dosage: 1575 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 09/19/2006.Mabthera Side Effects Report #5030843-5
Mabthera side effect was reported by a Physician from SPAIN on June 08, 2006. Female patient, 66 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hepatitis toxic, hepatotoxicity, pseudomonal sepsis, respiratory failure, septic shock. Mabthera dosage: 375 MG/M2, Q2M, INTRAVENOUS. During the same period patient was treated with PREDNISONE, CITALOPRAM, LORAZEPAM. Patient died on 07/11/2002.Mabthera Side Effects Report #5950683-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 03, 2008. Male patient, 50 years of age, was diagnosed with lymphoma
, dyspnoea and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hyperkalaemia, hyperuricaemia, hypocalcaemia, respiratory failure. Mabthera dosage: 600 MG, SINGLE. During the same period patient was treated with DEXAMETHASONE. Patient died on 11/01/2008.Mabthera Side Effects Report #5965109-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 17, 2008. Male patient, 50 years of age, was diagnosed with lymphoma
, dyspnoea, prophylaxis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hyperkalaemia, hyperuricaemia, hypocalcaemia, respiratory failure. Mabthera dosage: 600 MG, SINGLE. During the same period patient was treated with DEXAMETHASONE. Patient died on 11/01/2008.Mabthera Side Effects Report #5113539-0
Mabthera side effect was reported by a Physician from CHINA on Sept 08, 2006. Male patient, 38 years of age, weighting 165.3 lb, was diagnosed with lymphadenopathy and was treated with Mabthera. After drug was administered, patient experienced the following side effects: areflexia, polyneuropathy, respiratory failure, shock. Mabthera dosage: unknown. Patient was hospitalized and became disabled. Patient died on 07/16/2006.
Mabthera Side Effects Report #4644290-9
Mabthera side effect was reported by a Physician from on Apr 13, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ETOPOSIDE, DISALUNIL, BISOPROLOL, OMNIC. Patient was hospitalized. Patient died on 03/28/2005.Mabthera Side Effects Report #4661220-4
Mabthera side effect was reported by a Physician from on May 09, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ETOPOSIDE, DISALUNIL, BISOPROLOL, OMNIC. Patient was hospitalized. Patient died on 03/28/2005.Mabthera Side Effects Report #4629459-1
Mabthera side effect was reported by a Physician from on Mar 23, 2005. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, cough, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4633269-9
Mabthera side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient died.Mabthera Side Effects Report #5800705-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 19, 2008. Female patient, 60 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: respiratory failure. Mabthera dosage: 600 MG, Q21D. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, METHOTREXATE. Patient died.
Mabthera Side Effects Report #4885940-1
Mabthera side effect was reported by a Physician from GERMANY on Jan 02, 2006. Female patient, 57 years of age, weighting 158.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aspergillosis, lung infiltration, pancytopenia, respiratory failure. Mabthera dosage: 615 MG, INTRAVENOUS. During the same period patient was treated with MESNA, METOPROLOL SUCCINATE, CALCIUM, ACETYLCYSTEINE, OXOZEPAM, TRAMADOL, VERGENTAN, STEM CELLS. Patient died on 07/23/2005.
Mabthera Side Effects Report #5268633-0
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2007. Male patient, 33 years of age, weighting 180.8 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: adenovirus infection, diarrhoea, hepatitis
, respiratory failure. Mabthera dosage: 375 MG/KG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE. Patient died on 02/12/2007.Mabthera Side Effects Report #4971510-3
Mabthera side effect was reported by a Physician from GERMANY on Mar 16, 2006. Male patient, 59 years of age, weighting 127.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: dysentery, fluid intake reduced, multi-organ failure, pleural effusion, rash
, renal impairment, respiratory failure, sepsis . Mabthera dosage: 649 MG, QD, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, CLARITHROMYCIN, CEFUROXIME, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, TRAMADOL, ALLOPURINOL. Patient was hospitalized. Patient died on 03/03/2006.Mabthera Side Effects Report #5357687-9
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 08, 2007. Female patient, 62 years of age, was diagnosed with b-cell lymphoma, rheumatoid arthritis
, hypertension, osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, pulmonary fibrosis , respiratory failure. Mabthera dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, PERINDOPRIL, CALCIUM CHLORIDE, ALPHA D. Patient recovered.Mabthera Side Effects Report #5368099-6
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Female patient, 62 years of age, was diagnosed with b-cell lymphoma, rheumatoid arthritis
, hypertension, osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, pulmonary fibrosis , respiratory failure. Mabthera dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, PERINDOPRIL, CALCIUM CHLORIDE, ALPHA D. Patient recovered.Mabthera Side Effects Report #5386530-7
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 06, 2007. Female patient, 62 years of age, was diagnosed with b-cell lymphoma, rheumatoid arthritis
, hypertension, osteoporosis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, pulmonary fibrosis , respiratory failure. Mabthera dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, PERINDOPRIL, CALCIUM CHLORIDE, ALPHA D. Patient recovered.Mabthera Side Effects Report #5196382-6
Mabthera side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Dec 18, 2006. Male patient, 53 years of age, weighting 163.1 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pulmonary embolism
, respiratory failure. Mabthera dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient died on 10/09/2006.Mabthera Side Effects Report #5357888-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 05, 2007. Male patient, weighting 176.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: coma, respiratory failure. Mabthera dosage: unknown. Patient died.
Mabthera Side Effects Report #5365598-8
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 05, 2007. Male patient, weighting 176.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: coma, disease progression, respiratory failure. Mabthera dosage: unknown. Patient died.
Mabthera Side Effects Report #5670065-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Mar 04, 2008. Male patient, weighting 185.2 lb, was diagnosed with b-cell lymphoma, autoimmune thrombocytopenia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: respiratory failure. Mabthera dosage: 716 MG, UNK. Patient recovered.
Mabthera Side Effects Report #6012631-6
Mabthera side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 04, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: infusion related reaction, respiratory failure. Mabthera dosage: 375 MG/M2, UNK. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #6025684-6
Mabthera side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 18, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: infusion related reaction, respiratory failure. Mabthera dosage: 375 MG/M2, UNK. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5692505-0
Mabthera side effect was reported by a Consumer or non-health professional from CHINA on Mar 21, 2008. Female patient, weighting 12.13 lb, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, heart rate increased, pyrexia, respiratory failure. Mabthera dosage: 100 MG, UNK. Patient died on 03/21/2008.
Mabthera Side Effects Report #5718655-8
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient, weighting 121.3 lb, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: candidiasis, cryptogenic organising pneumonia, klebsiella infection, no therapeutic response, respiratory failure, sputum culture positive, superinfection. Mabthera dosage: 560 MG, 1/WEEK. Patient was hospitalized and became disabled. Patient recovered.